Abstract
Cerebral ischemia–reperfusion (CIR) injury exerts a potential threat on neuronal cell survival. Cerebral ischemia, a type of stroke, ensues due to occlusion of oxygen in common carotid arteries and blockage of nutrients in brain tissues. It is the most common and lethal neurological disorder especially in the aged individuals. When neuronal cells become deprived of sufficient oxygen because of low blood flow rate following ischemic stroke, a cascade of events occurs, leading to cell death by toxicity and oxidative stress. Oxidative stress appears to be an important role in CIR injury wherein a large amount of reactive oxygen species generated by the mitochondria provokes the release of cytochrome c and other apoptotic proteins, leading to defective gene expression and subsequent cell death. Under CIR, natural defense mechanism fails to protect neurons from oxidative damage. Matrix metalloproteinases (MMPs), mainly MMP-2 and MMP-9, are elevated after cerebral ischemia which are involved in accelerating matrix degradation, disrupting the blood–brain barrier (BBB), and increasing the neuronal infarct size. Some compounds (flavonoids, antioxidants, MMP inhibitors) show the potency as neuroprotectant against CIR. Question arises how to reduce the cytotoxicity of the compounds and overcome the BBB permeability? Over the past few years, different vesicular formulations, especially liposome and nanocapsule, have received attention as effective modality in enhancing therapeutic concentration while rescuing CIR. This chapter is focused on the mechanism of MMPs’ action during CIR injury and to delineate the effect of MMP inhibitors and antioxidants with their different formulations in modulating MMP activity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Soler EP & Ruiz VC (2010) Epidemiology and risk factors of cerebral ischemia and ischemic heart diseases: similarities and differences. Curr Cardiol Rev 6:138-149
Donnan GA, Fisher M, Macleod M et al (2008) The secondary prevention of stroke. The Lancet 372:1036
Mathers CD, Boerma T, Ma Fat D (2009) Global and regional causes of death. Brit Med Bull 92:7-32
Lakhan S, Kirchgessner A, Hofer M (2009) Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med 7:97
Sims NR, Muyderman H (2010) Mitochondria, oxidative metabolism and cell death in stroke. BBA – Mol Basis Dis 1802:80-91
Khatri R, McKinney AM, Swenson B et al (2012) Blood–brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke. Neurology 79: S52-57
Stanimirovic D , Satoh K (2000) Inflammatory mediators of cerebral endothelium: a role in ischemic brain inflammation. Brain Pathol 10:113-126
Ritter LS, Orozco JA, Coull BM et al (2000) Leukocyte accumulation and hemodynamic changes in the Cerebral Microcirculation during early reperfusion after Stroke. Stroke 31:1153-1161
Sugawara T, Fujimura M, Noshita N et al (2004) Neuronal death/survival signaling pathways in cerebral ischemia. Neurotherapeutics 1:17-25
Dale N, Frenguelli BG (2009) Release of adenosine and ATP during ischemia and epilepsy. Curr Neuropharmacology 7:160-179
Bora KS, Sharma A (2011) Evaluation of Antioxidant and Cerebroprotective Effect of Medicago sativa Linn. against Ischemia and Reperfusion Insult. J Evid Based Complementary Altern Med 2011:792167
Greve MW, Zink BJ (2009) Pathophysiology of traumatic brain injury. Mount Sinai Journal of Medicine: J Translat Personalized Med 76:97-104
Atlee JL (2007) ed. Complications in Anesthesia, 2nd ed. Philadelphia: Saunders Elsevier, 2007:508-4512
Siesjö BK (1992) Pathophysiology and treatment of focal cerebral ischemia. J Neurosurg 77:337-354
Stamatovic SM, Keep RF, Andjelkovic AV (2008) Brain endothelial cell-cell junctions: how to “open” the blood brain barrier. Curr Neuropharmacol 6:179-192
Kundu P, Mukhopadhyay AK, Patra R et al (2006) Cag Pathogenicity Island-independent Up-regulation of Matrix Metalloproteinases-9 and −2 Secretion and Expression in Mice by Helicobacter pylori Infection. J Biol Chem 281:34651-34662
Hermann DM, Matter CM (2007) Tissue Plasminogen Activator–Induced Reperfusion Injury After Stroke Revisited. Circulation 116:363-365
Ceulemans A-G, Zgavc T, Kooijman R et al (2010) The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia. J. of Neuroinflam. 7:74
Cheng T, Petraglia AL, Li Z et al (2006) Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage. Nat Med 12:1278-1285
Kilic E, Kilic Ü, Reiter RJ, Bassetti CL et al (2005) Tissue-plasminogen activator-induced ischemic brain injury is reversed by melatonin: role of iNOS and Akt. J Pineal Res 39:151-155
Kilic E, Kilic U, Matter CM et al (2005) Aggravation of Focal Cerebral Ischemia by Tissue Plasminogen Activator Is Reversed by 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor but Does Not Depend on Endothelial NO Synthase. Stroke 36:332-336
Zhang L, Zhang ZG, Ding GL et al (2005) Multitargeted Effects of Statin-Enhanced Thrombolytic Therapy for Stroke With Recombinant Human Tissue-Type Plasminogen Activator in the Rat. Circulation 112:3486-3494
Liu D, Cheng T, Guo H et al (2004) Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C. Nat Med 10:1379-1383
Tsay HJ, Wang P, Wang SL et al (2000) Age-associated changes of superoxide dismutase and catalase activities in the rat brain. J Biomed Sci 7:466-474
Amirkhizi F, Siassi F, Djalali M et al (2010) Assessment of antioxidant enzyme activities in erythrocytes of pre-hypertensive and hypertensive women. J Res Med Sci 15:270-278
Verstraete M, Bounameaux H, de Cock F et al (1985) Pharmacokinetics and systemic fibrinogenolytic effects of recombinant human tissue-type plasminogen activator (rt-PA) in humans. J Pharm Exp Ther 235:506-512
Matsumiya N, Koehler RC, Kirsch JR et al (1991) Conjugated superoxide dismutase reduces extent of caudate injury after transient focal ischemia in cats. Stroke 22:1193-1200
Michowiz SD, Melamed E, Pikarsky E et al (1990) Effect of ischemia induced by middle cerebral artery occlusion on superoxide dismutase activity in rat brain. Stroke 21:1613-1617
Mahadik SP, Makar TK, Murthy JN et al (1993) Temporal changes in superoxide dismutase, glutathione peroxidase, and catalase levels in primary and peri-ischemic tissue. Monosialoganglioside (GM1) treatment effects. Mol Chem Neuropathol 18:1-14
Tasdemiroglu E, Chistenberry PD, Ardell JL et al (1993) Effect of superoxide dismutase on acute reperfusion injury of the rabbit brain. Acta Neurochir (Wien) 120:180-186
Yamaguchi K, Uematsu D, Itoh Y et al (2002) In vivo measurement of superoxide in the cerebral cortex during anoxia-reoxygenation and ischemia-reperfusion. Keio J Med 51:201-207
Chaudhary G, Sinha K, Gupta YK (2003) Protective effect of exogenous administration of α-tocopherol in middle cerebral artery occlusion model of cerebral ischemia in rats. Fundam Clin Pharm 17:703-707
Truelove D, Shuaib A, Ijaz S et al (1994) Superoxide dismutase, catalase, and U78517F attenuate neuronal damage in gerbils with repeated brief ischemic insults. Neurochem Res 19:665-671
Maier CM, Ahern K, Cheng ML et al (2002) Effects of Mild Hypothermia on Superoxide Anion Production, Superoxide Dismutase Expression, and Activity Following Transient Focal Cerebral Ischemia. Neurobiol Dis 11:28-42
Khaira HS, Maxwell SR, Thomason H et al (1996) Antioxidant depletion during aortic aneurysm repair. Brit J Surg 83:401-403
Berman K, Brodaty H (2004) Tocopherol (vitamin E) in Alzheimer’s disease and other neurodegenerative disorders. CNS Drugs 18:807-825
Sanossian N, Ovbiagele B (2009) Prevention and management of stroke in very elderly patients. The Lancet Neurology 8:1031-1041
Stam J (2005) Thrombosis of the Cerebral Veins and Sinuses. New Engl J Med 352:1791-1798
Brunner LS, Smeltzer SCOC, Bare BG et al (2008) Brunner and Suddarth’s Textbook of Medical Surgical Nursing 11th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins p.1527
Ellerbroek SM, Halbleib JM, Benavidez M et al (2001) Phosphatidylinositol 3-Kinase Activity in Epidermal Growth Factor-stimulated Matrix Metalloproteinase-9 Production and Cell Surface Association. Cancer Res. 61:1855-186
Liu J-F, Crépin M, Liu J-M et al (2002) FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. Biochem Bioph Res Co 293:1174-1182
Ruhul Amin ARM, Senga T, Oo ML et al (2003) Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1β: a role for the dual signalling pathways, Akt and Erk. Genes to Cells 8:515-523
Suyama K, Shapiro I, Guttman M et al (2002) A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2:301-314
Busti C, Falcinelli E, Momi S et al (2010) Matrix metalloproteinases and peripheral arterial disease. Intern Emerg Med 5:13-25
Coussens LM, Tinkle CL, Hanahan D et al (2000) MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis. Cell 103:481-490
Ho T-Y, Bagnell CA (2005) Relaxin Induces Matrix Metalloproteinase-9 through Activation of Nuclear Factor Kappa B in Human THP-1 Cells. Ann NY Acad Sci 1041:314-316
Jintang S, Feng A, Zhang Y et al (2010) Fucoidan increases TNF-α-induced MMP-9 secretion in monocytic cell line U937. Inflamm Res 59:271-276
Chakraborti S, Mandal M, Das S et al (2003) Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 253:269-285
Ma Z, Shah RC, Chang MJ et al (2004) Coordination of cell signaling, chromatin remodeling, histone modifications, and regulator recruitment in human matrix metalloproteinase 9 gene transcription. Mol Cell Biol 24:5496-5509
Gidday JM, Gasche YG, Copin JC et al (2005) Leukocyte-derived matrix metalloproteinase-9 mediates blood–brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am J Physiol - Heart C 289:558-568
Wang G, Guo Q, Hossain M et al (2009) Bone marrow-derived cells are the major source of MMP-9 contributing to blood–brain barrier dysfunction and infarct formation after ischemic stroke in mice. Brain Res 1294:183-192
Gasche Y, Fuzimura Y, Copin J et al (1999) Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood–brain barrier dysfunction. J Cerebr Blood F Met 19:1020-1028
Planas AM, Solé S, Justicia C (2001) Expression and Activation of Matrix Metalloproteinase-2 and −9 in Rat Brain after Transient Focal Cerebral Ischemia. Neurobiol Dis 8:834-846
Romanic AM, White RF, Arleth AJ et al (1998) Matrix Metalloproteinase Expression Increases After Cerebral Focal Ischemia in Rats: Inhibition of Matrix Metalloproteinase-9 Reduces Infarct Size. Stroke 29:1020-1030
Montaner J, Alvarez-Sabin J, Molina C et al (2001) Matrix Metalloproteinase Expression After Human Cardioembolic Stroke: Temporal Profile and Relation to Neurological Impairment. Stroke 32:1759-1766
Rosell A, Ortega-Aznar A, Alvarez-Sabin-J et al (2006) Increased Brain Expression of Matrix Metalloproteinase-9 After Ischemic and Hemorrhagic Human Stroke. Stroke 37:1399-1406
Park K-P, Rossel A, Foerch C et al (2009) Plasma and Brain Matrix Metalloproteinase-9 after acute focal Cerebral Ischemia in rats. Stroke 40:2836-2842
Horstmann S, Kalb P, Koziol J et al (2003) Profiles of Matrix Metalloproteinases, their Inhibitors, and Laminin in Stroke patients: Influence of different therapies. Stroke 34:2165-2170
Montaner J, Rovira A, Molina CA et al (2003) Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke. J Cerebr Blood F Met 23:1403-1407
Castellanos M, Leira R, Serena J et al (2003) Plasma Metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke 34:40-46
Montaner J, Alvarez-Sabin J, Molina CA et al (2001) Matrix Metalloproteinase expression is related to hemorrhagic transformation after Cardioembolic Stroke. Stroke 32:2762-2767
Gurney KJ, Estrada EY, Rosenberg GA (2006) Blood–brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation. Neurobiol Dis 23:87-96
Sole S, Petegnief V, Gorina R, Chamorro A et al (2004) Activation of matrix metalloproteinase-3 and agrin cleavage in cerebral ischemia/reperfusion. J Neuropathol Exp Neur 63:338-349
Kontos HA (1985) George E. Brown memorial lecture. Oxygen radicals in cerebral vascular injury. Circul Res 57:508-516
Siesjo BK, Agardh CD, Bengtsson F (1989) Free radicals and brain damage. Cerebrovasc Brain Metab Rev 1:165-211
Chan PH (1994) Oxygen radicals in focal cerebral ischemia. Brain Pathol 4(1):59-65
Boveris A & Chance B (1973) The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 134(3):707-716
Koh J, Choi D (1988) Vulnerability of cultured cortical neurons to damage by excitotoxins: differential susceptibility of neurons containing NADPH-diaphorase. J Neurosci 8:2153-2163
Iadecola C (1997) Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 20:132-139
Zhang ZG, Chopp M, Zaloga C et al (1993) Cerebral endothelial nitric oxide synthase expression after focal cerebral ischemia in rats. Stroke 24:2016-2021
Beasley TC, Bari F, Thore C et al (1998) Cerebral ischemia/reperfusion increases endothelial nitric oxide synthase levels by an indomethacin-sensitive mechanism. J Cerebr Blood F Met 18:88-96
Xu J, HE L, Ahmed S H et al (2000) Oxygen-Glucose Deprivation Induces Inducible Nitric Oxide Synthase and Nitrotyrosine Expression in Cerebral Endothelial Cells. Stroke 31:1744-1751
Nogawa S, Forster C, Zhang F et al (1998) Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc Natl Acad Sci 95:10966-10971
Chan PH (2001) Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cerebr Blood F Met 21:2-14
Noshita N, Sugawara T, Fujimura M et al (2001) Manganese Superoxide Dismutase Affects Cytochrome c Release and Caspase-9 Activation After Transient Focal Cerebral Ischemia in Mice. J Cerebr Blood F Met 21:557-567
Xanthoudakis S, Miao G, Wang F et al (1992) Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. Embo J 11:3323-3335
Bennett RAO, Wilson DM, Wong D et al (1997) Interaction of human apurinic endonuclease and DNA polymerase β in the base excision repair pathway. Proc Natl Acad Sci 94:7166-7169
Robertson KA, Hill DP , Xu Y et al (1997) Down-regulation of apurinic/apyrimidinic endonuclease expression is associated with the induction of apoptosis in differentiating myeloid leukemia cells. Cell Growth Differ 8:443-449
Edwards M, Kent TA, Rea HC et al (1998) APE/Ref-1 responses to ischemia in rat brain. Neuroreport 9:4015-4018
Kawase M, Fujimura M, Morita-Fujimura Y et al (1999) Reduction of Apurinic/Apyrimidinic Endonuclease Expression After Transient Global Cerebral Ischemia in Rats: Implication of the Failure of DNA Repair in Neuronal Apoptosis. Stroke 30:441-449
Fujimura M, Morita-Fuzimura Y, Narasimhan P et al (1999) Copper-Zinc Superoxide Dismutase Prevents the Early Decrease of Apurinic/Apyrimidinic Endonuclease and Subsequent DNA Fragmentation After Transient Focal Cerebral Ischemia in Mice. Stroke 30:2408-2415
Sen CK (1998) Redox Signaling and the Emerging Therapeutic Potential of Thiol Antioxidants. Biochem Pharmacol 55:1747-1758
Dalton TP, Shertzer HG, Puga A (1999) Regulation of gene expression by reactive oxygen. Annu Rev Pharmacol 39:67-101
Yu Z, Zhou D, Bruce-Keller AJ, Kindy MS et al (1999) Lack of the p50 Subunit of Nuclear Factor-κB Increases the Vulnerability of Hippocampal Neurons to Excitotoxic Injury. J Neurosci 19:8856-8865
Kuo PC, Abe K, Schroeder RA (2000) Superoxide enhances interleukin 1beta-mediated transcription of the hepatocyte-inducible nitric oxide synthase gene. Gastroenterol Jpn 118:608-618
Morita-Fujimura Y, Fujimura M, Kawase M et al (1999) Early decrease in apurinic/apyrimidinic endonuclease is followed by DNA fragmentation after cold injury-induced brain trauma in mice. J Neurosci 93:1465-1473
Morita-Fujimura Y, Fujimura M, Gasche Y et al (2000) Overexpression of copper and zinc superoxide dismutase in transgenic mice prevents the induction and activation of matrix metalloproteinases after cold injury-induced brain trauma. J Cerebr Blood F Met 20:130-138
Yrjanheikki J, Chan PH (2000) Spreading depression-induced expression of c-fos and cyclooxygenase-2 in transgenic mice that overexpress human copper/zinc-superoxide dismutase. J Neurotraum 17:713-718
Carden DL, Granger DN (2000) Pathophysiology of ischaemia–reperfusion injury. J Pathol 190:255-266
Bolli R, Jeroudi MO, Patel B S et al (1989) Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog. Proc Natl Acad Sci 86:4695-4699
Marklund SL (1982) Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci 79:7634-7638
He YY, Hsu CY, Ezrin AM et al (1993) Polyethylene glycol-conjugated superoxide dismutase in focal cerebral ischemia-reperfusion. Am J Physiol. 265:252-256
Chan PH, Epstein CJ, Li Y et al (1994) SOD-1 Transgenic Mice as a Model for Studies of Neuroprotection in Stroke and Brain Trauma. Ann N Y Acad Sci 738:93-103
Imaizumi S, Woolworth V, Fishman RA et al (1990) Liposome-entrapped superoxide dismutase reduces cerebral infarction in cerebral ischemia in rats. Stroke 21:1312-1317
Chan PH, Longar S, Fishman RA (1987) Protective effects of liposome-entrapped superoxide dismutase on posttraumatic brain edema. Ann Neurol 21:540-547
Epstein CJ, Avraham KV, Lovett M et al (1987) Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc Natl Acad Sci 84:8044-8048
Havsteen B (1983) Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 32:1141-1148
Geetha T, Malhotra V, Chopra K et al (2005) Antimutagenic and antioxidant/prooxidant activity of quercetin. Ind J Exp Biol 43:61-67
Coleridge Smith PD, Thomas P et al (1988) Causes of venous ulceration: a new hypothesis. Br Med J (Clin Res Ed) 296:1726-1727
Chakraborty S, Sami S, Das N et al (2012) The use of nano-quercetin to arrest mitochondrial damage and MMP-9 upregulation during prevention of gastric inflammation induced by ethanol in rat. Biomaterials 33:2991-3001
Heo HJ, Lee CY (2004) Protective Effects of Quercetin and Vitamin C against Oxidative Stress-Induced Neurodegeneration. J Agric Food Chem 52:7514-7517
Pace-Asciak CR, Hahn S, Diamandis EP et al (1995) The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease. Clin Chim Acta 235:207-219
Huk I, Brokovich V, Villi J N et al (1998) Bioflavonoid quercetin scavenges superoxide and increases nitric oxide concentration in ischaemia–reperfusion injury: an experimental study. Br J Surg 85:1080-1085
Ahlemeyer B, Krieglstein J (2003) Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer’s disease. Pharmacopsychiatry 36:8-14
Chandrasekaran K, Mehrabian Z, Spinnewyn B et al (2003) Neuroprotective effects of bilobalide, a component of Ginkgo biloba extract (EGb 761) in global brain ischemia and in excitotoxicity-induced neuronal death. Pharmacopsychiat. 36:89-94
Chung SY, Wang MF, Lin JY et al (2003) Effect of one week treatment with Ginkgo biloba extract (EGb761) on ischemia-induced infarct volume in gerbils. Am J Chin Med 31:533-542
Donato G, Volpentesta G, Lavano A et al (2003) Effects of Ginko Biloba and caspase inhibitors on brain ischemia in the Mongolian Gerbil. J Neurosurg Sci 47:149-155
Ovbiagele B, Kidwell CS, Starkman S et al (2003) Potential Role of Neuroprotective Agents in the Treatment of Patients with Acute Ischemic Stroke. Curr Treat Options Cardiovasc Med 5:441-449
Hatcher JF, Dempsey RJ (2002) Citicoline: neuroprotective mechanisms in cerebral ischemia. J Neurochem 80:12-23
Secades JJ, Lorenzo JL (2006) Citicoline: pharmacological and clinical review, 2006 update. Methods Find Exp Clin Pharmacol 28 :1-56
Mandal AK, Das S, Basu MK et al (2007) Hepatoprotective Activity of Liposomal Flavonoid against Arsenite-Induced Liver Fibrosis. J Pharmacol Exp Ther 320:994-1001
Forsman M, Fleischer JE, Milde JH et al (1988) Superoxide dismutase and catalase failed to improve neurologic outcome after complete cerebral ischemia in the dog. Acta Anaesthesiol Scand 32:152-155
Fresta M, Puglisi G (1997) Survivalrate improvement in a rat ischemia model by long circulating liposomes containing cytidine-5′-diphosphate choline. Life Sci 61:1227-1235
Regnier-Vigouroux A (2003) The mannose receptor in the brain. Int Rev Cytol 226:321-342
Galea I, Palin K, Newman TA et al (2005) Mannose receptor expression specifically reveals perivascular macrophages in normal, injured, and diseased mouse brain. Glia 49:375-384
Irache JM, Salman HH, Gamazo C et al (2008) Mannose-targeted systems for the delivery of therapeutics. Expert Opin Drug Deliv 5:703-724
Umezawa F, Eto Y (1988) Liposome targeting to mouse brain: Mannose as a recognition marker. Biochem Biophys Res Commun 153:1038-1044
Fresta M, Puglisi G (1999) Reduction of maturation phenomenon in cerebral ischemia with CDP-choline-loaded liposomes. Pharm Res 16:1843-1849
Das S , Mandal AK, Ghosh A et al (2008) Nanoparticulated quercetin in combating age related cerebral oxidative injury. Curr Aging Sci 1:169-174
Stamenkovic I (2003) Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 200:448-464
Lu P, Weaver VM, Werb Z (2012) The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 196:395-406
Whittaker CA, Bergeron KF, Whittle J et al (2006) The echinoderm adhesome. Dev Biol 300:252-266
Özbek S, Balasubramanian PG, Chiquet-Ehrismann R et al (2010) The Evolution of Extracellular Matrix. Mol Biol Cell 21:4300-4305
Rohrbach DH, Timpl R (eds) (1993) Molecular and cellular aspects of basement membranes (Academic Press) San Diego, CA, 49–66
Egeblad M, Rasch MG, Weaver VM (2010) Dynamic interplay between the collagen scaffold and tumor evolution. Curr Opin Cell Biol 22:697-7
Godenschwege TA, Pohar N, Buchner S et al (2000) Inflated wings, tissue autolysis and early death in tissue inhibitor of metalloproteinases mutants of Drosophila. Eur J Cell Biol 79:495-501
Jones FS, Jones PL (2000) The tenascin family of ECM glycoproteins: Structure, function, and regulation during embryonic development and tissue remodeling. Dev Dyn 218:235-259
Rauch U, Feng K, Zhou XH (2001) Neurocan: a brain chondroitin sulfate proteoglycan. Cell Mol Life Sci 58:1842-1856
McDonald J, Hascall VC (2002) Hyaluronan Minireview Series. J Biol Chem 277:4575-4579
Knudson W (1996) Tumor-associated hyaluronan. Providing an extracellular matrix that facilitates invasion. Am J Pathol 148:1721-1726
Termeer C, Sleeman JP, Simon JC (2003) Hyaluronan – magic glue for the regulation of the immune response? Trends Immunol 24:112-114
Fitch MT, Silver J (1997) Activated Macrophages and the Blood–Brain Barrier: Inflammation after CNS Injury Leads to Increases in Putative Inhibitory Molecules. Exp Neurol 148:587-603
Davies SJ, Fitch MT, Memberg SP et al (1997) Regeneration of adult axons in white matter tracts of the central nervous system. Nature 390:680-683
Hirakawa S, Oohashi T, Su W-D et al (2000) The Brain Link Protein-1 (BRAL1): cDNA Cloning, Genomic Structure, and Characterization as a Novel Link Protein Expressed in Adult Brain. Biochem Biophys Res Commun 276:982-989
Milev P, Maurel P, Chiba A et al (1998) Differential Regulation of Expression of Hyaluronan-Binding Proteoglycans in Developing Brain: Aggrecan, Versican, Neurocan, and Brevican. Biochem Biophys Res Commun 247:207-212
Margolis RU, Margolis RK, Chang LB et al (1975) Glycosaminoglycans of brain during development. Biochemistry 14:85-88
Yamaguchi Y (1996) Brevican: a major proteoglycan in adult brain. Perspect Dev Neurobiol 3:307-317
Schmalfeldt M, Dours-Zimmermann MaT, Winterhalter KH et al (1998) Versican V2 Is a Major Extracellular Matrix Component of the Mature Bovine Brain. J Biol Chem 273:15758-15764
Pesheva P, Spiess E, Schachner M (1989) J1-160 and J1-180 are oligodendrocyte-secreted nonpermissive substrates for cell adhesion. J Cell Biol 109:1765-1778
Rauch U, Gao P, Janetzko A et al (1991) Isolation and characterization of developmentally regulated chondroitin sulfate and chondroitin/keratan sulfate proteoglycans of brain identified with monoclonal antibodies. J Biol Chem 266:14785-14801
Dörries U, Schachner M (1994) Tenascin mRNA isoforms in the developing mouse brain. J Neurosci Res 37:336-347
Tomimatsu Y, Idemoto S, Moriguchi S et al (2002) Proteases involved in long-term potentiation. Life Sci 72:355-361
Indyk JA, Chen ZL, Tsirka SE et al (2003) Laminin chain expression suggests that laminin-10 is a major isoform in the mouse hippocampus and is degraded by the tissue plasminogen activator/plasmin protease cascade during excitotoxic injury. Neurosci 116:359-371
Matthews RT, Gary SC, Zerillo C et al (2000) Brain-enriched Hyaluronan Binding (BEHAB)/Brevican Cleavage in a Glioma Cell Line Is Mediated by a Disintegrin and Metalloproteinase with Thrombospondin Motifs (ADAMTS) Family Member. J Biol Chem 275:22695-22703
Westling J, Gottschall PE, Thompson V P et al (2004) ADAMTS4 (aggrecanase-1) cleaves human brain versican V2 at Glu405-Gln406 to generate glial hyaluronate binding protein. Biochem J 377:787-795
Satoh K, Suzuki N, Yokota H (2000) ADAMTS-4 (a disintegrin and metalloproteinase with thrombospondin motifs) is transcriptionally induced in beta-amyloid treated rat astrocytes. Neurosci Lett 289:177-180
Sandy JD, Westling J, Kenagy RD et al (2001) Versican V1 Proteolysis in Human Aorta in Vivo Occurs at the Glu441-Ala442 Bond, a Site That Is Cleaved by Recombinant ADAMTS-1 and ADAMTS-4. J Biol Chem 276:13372-13378
Lee S-R, Tsuji K, Lee S-R et al (2004) Role of Matrix Metalloproteinases in delayed neuronal damage after transient global cerebral ischemia. J Neurosci 24:671-678
Lu A, Tang Y, Ran R et al (2003) Genomics of the periinfarction cortex after focal cerebral ischemia. J Cereb Blood Flow Metab 23:786-810
Nicholson C, Syková E (1998) Extracellular space structure revealed by diffusion analysis. Trends Neurosci 21:207-215
Novak U, Kaye AH (2000) Extracellular matrix and the brain: components and function. J Clin Neurosci 7:280-290
Mörgelin M, Heinegård D, Engel J et al (1994) The cartilage proteoglycan aggregate: assembly through combined protein—carbohydrate and protein—protein interactions. Biophys Chem 50:113-128
Yamaguchi Y (2000) Lecticans: organizers of the brain extracellular matrix. Cell Mol Life Sci 57:276-289
Bandtlow CE, Zimmermann DR (2000) Proteoglycans in the Developing Brain: New Conceptual Insights for Old Proteins. Physiol Rev 80:1267-1290
Miura R, Aspberg A, Ethell IM et al (1999) The Proteoglycan Lectin Domain Binds Sulfated Cell Surface Glycolipids and Promotes Cell Adhesion. J Biol Chem 274:11431-11438
Olin AI, Morgelin M, Sasaki T et al (2001) The Proteoglycans Aggrecan and Versican Form Networks with Fibulin-2 through Their Lectin Domain Binding. J Biol Chem 276:1253-1261
Rauch U, Clement A, Retzler C et al (1997) Mapping of a Defined Neurocan Binding Site to Distinct Domains of Tenascin-C. J Biol Chem 272:26905-26912
Aspberg A, Miura R, Bourdoulous S et al (1997) The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein– protein interactions independent of carbohydrate moiety. Proc Natl Acad Sci 94:10116-10121
Day JM, Olin AI, Murdoch AD et al (2004) Alternative Splicing in the Aggrecan G3 Domain Influences Binding Interactions with Tenascin-C and Other Extracellular Matrix Proteins. J Biol Chem 279:12511-12518
Chodobsky A, Zink B J, Chodobska J S (2011) Blood–brain barrier pathophysiology in traumatic brain injury. Transl Stroke Res 2: 492-516
Löffek S, Schilling O, Franzke C-W (2011) Biological role of matrix metalloproteinases: a critical balance. Eur Resp J 38:191-208
Jana S, Rudra DS, Paul S et al (2012) Curcumin delays endometriosis development by inhibiting MMP-2 activity. Indian J Biochem Biophys 49:342-348
Ganguly K, Kundu P, Banerjee A et al (2006) Hydrogen peroxide-mediated downregulation of matrix metalloprotease-2 in indomethacin-induced acute gastric ulceration is blocked by melatonin and other antioxidants. Free Radic Biol Med 41:911-925
Rosenberg GA, Estrada EY, Dencoff JE (1998) Matrix Metalloproteinases and TIMPs Are Associated With Blood–brain Barrier Opening After Reperfusion in Rat Brain. Stroke 29:2189-2195
Visse R, Nagase H (2003) Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases: Structure, Function, and Biochemistry. Circ Res 92:827-839
Swarnakar S, Mishra A, Chaudhuri SR (2012) The gelatinases and their inhibitors: the structure-activity relationships. EXS 103:57-82
Axisa B, Loftus I M, Naylor AR et al (2002) Prospective, Randomized, Double-Blind Trial Investigating the Effect of Doxycycline on Matrix Metalloproteinase Expression Within Atherosclerotic Carotid Plaques. Stroke 33:2858-2864
Morgan AR, Rerkasem K, Gallagher PJ et al (2004) Differences in Matrix Metalloproteinase-1 and Matrix Metalloproteinase-12 Transcript Levels Among Carotid Atherosclerotic Plaques With Different Histopathological Characteristics. Stroke 35:1310-1315
Mun-Bryce S, Rosenberg GA (1998) Matrix metalloproteinases in cerebrovascular disease. J Cereb Blood Flow Metab 18:1163-1172
Molloy KJ, Thompson MM, Jones JL et al (2004) Unstable Carotid Plaques Exhibit Raised Matrix Metalloproteinase-8 Activity. Circulation 110:337-343
Heo JH, Kim SH, Lee KY et al (2003) Increase in Plasma Matrix Metalloproteinase-9 in Acute Stroke Patients With Thrombolysis Failure. Stroke 34:48-e50
Cuzner ML, Gveric D, Strand C et al (1996) The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution. J Neuropathol Exp Neurol 55:1194-1204
Fukuda S, Fini CA, Mabuchi T et al (2004) Focal Cerebral Ischemia Induces Active Proteases That Degrade Microvascular Matrix. Stroke 35:998-1004
Pfefferkorn T, Rosenberg GA (2003) Closure of the Blood–brain Barrier by Matrix Metalloproteinase Inhibition Reduces rtPA-Mediated Mortality in Cerebral Ischemia With Delayed Reperfusion. Stroke 34:2025-2030
Eldrup N, Grønholdt M-LM, Sillesen H et al (2006) Elevated Matrix Metalloproteinase-9 Associated With Stroke or Cardiovascular Death in Patients With Carotid Stenosis. Circulation 114:1847-1854
Zalewska T, Ziemka-Nalecz M, Sarnowska A et al (2002) Involvement of MMPs in delayed neuronal death after global ischemia. Acta Neurobiol Exp (Wars) 62(2):53-61
Hashimoto T, Wen G, Lawton MT et al (2003) Abnormal Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Brain Arteriovenous Malformations. Stroke 34:925-931
Lapchak PA, Chapman DF, Zivin JA (2000) Metalloproteinase Inhibition Reduces Thrombolytic (Tissue Plasminogen Activator)–Induced Hemorrhage After Thromboembolic Stroke. Stroke 31:3034-3040
Montaner J, Molina CA, Monasterio J et al (2003) Matrix Metalloproteinase-9 Pretreatment Level Predicts Intracranial Hemorrhagic Complications After Thrombolysis in Human Stroke. Circulation 107:598-603
Singh LP, Mishra A, Saha D et al (2011) Doxycycline blocks gastric ulcer by regulating matrix metalloproteinase-2 activity and oxidative stress. World J Gastroenterol 17:3310-3321
Acknowledgments
Sibani Sarkar and Somnath Chatterjee contributed equally to the manuscript. Sibani Sarkar is the recipient of woman scientist award from DST, India. Prof. Siddhartha Roy, the Director of the CSIR-IICB, Kolkata, is acknowledged for providing all the supports. Authors are also thankful to Mr. Sayantan Jana for his unconditional help in the preparation of the figures.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sarkar, S., Chatterjee, S., Swarnakar, S. (2014). Matrix Metalloproteinases in Ischemia–Reperfusion Injury in Brain: Antioxidants as Rescuer. In: Dhalla, N., Chakraborti, S. (eds) Role of Proteases in Cellular Dysfunction. Advances in Biochemistry in Health and Disease, vol 8. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9099-9_4
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9099-9_4
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9098-2
Online ISBN: 978-1-4614-9099-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)